2025-01-30 - Analysis Report
## Air Products and Chemicals Inc. (APD) Stock Review

**1. Performance Comparison and Divergence:**

Air Products and Chemicals Inc. (APD) is a leading industrial gas company providing atmospheric, process, and specialty gases.  Over the reviewed period, APD's cumulative return (95.43%) lagged behind the S&P 500 (VOO) cumulative return (119.94%) by 24.5 percentage points.  This places its performance at the 28.1st percentile relative to its historical performance range against the S&P 500 (-58.5% to +62.4%).  While the CAGR (Compound Annual Growth Rate) has been strong in some periods, recent performance shows a decline.

**Alpha and Beta Analysis:**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 22.0% | 0.0% | -6.0% | 0.2 | 30.8 |
| 2016-2018  | 29.0% | 6.2% | 10.0% | 0.2 | 30.9 |
| 2017-2019  | 59.0% | 6.2% | 28.0% | 0.2 | 46.4 |
| 2018-2020  | 56.0% | 7.6% | 29.0% | 0.2 | 55.1 |
| 2019-2021  | 73.0% | 7.6% | 2.0% | 0.2 | 62.7 |
| 2020-2022  | 24.0% | 15.7% | 16.0% | 0.2 | 65.1 |
| 2021-2023  | -12.0% | 15.7% | -35.0% | 0.2 | 59.3 |
| 2022-2024  | -7.0% | 15.7% | -40.0% | 0.2 | 64.1 |
| 2023-2025  | -4.0% | 12.9% | -64.0% | 0.2 | 72.8 |

The beta of approximately 0.2 consistently indicates low correlation with the overall market.  However, the negative alpha in recent periods highlights underperformance relative to the benchmark.

**2. Recent Price Movement:**

* **Closing Price:** $327.31
* **5-Day Moving Average:** $326.84
* **20-Day Moving Average:** $305.38
* **60-Day Moving Average:** $310.38

The price is above its 5-day moving average, suggesting short-term upward momentum. However, it's significantly above the 20-day and 60-day moving averages, potentially indicating overbought conditions.  The recent price increase (+$0.09) is minor and doesn't signal a significant rapid jump.


**3. Technical Indicators and Expected Return:**

* **RSI:** 86.54 – This extremely high RSI value strongly suggests the stock is overbought and potentially due for a correction.
* **PPO:** 1.10 – A positive PPO indicates bullish momentum.
* **20-Day Relative Strength Change:** +6.4% - Shows recent short-term upward momentum.
* **Expected Return (2+ years):** -1.1% -  This indicates that, based on current projections, long-term investment in APD may underperform the S&P 500.


**4. Recent Earnings Analysis:**

| Date       | EPS    | Revenue      |
|------------|--------|---------------|
| 2024-08-01 | 3.13   | $2.99 B      |
| 2024-04-30 | 2.57   | $2.93 B      |
| 2024-02-05 | 2.74   | $3.00 B      |
| 2023-08-03 | 2.68   | $3.03 B      |
| 2024-08-01 | 2.68   | $3.03 B      | *(Note: Duplicate entry, likely an error)*


EPS shows some fluctuation, but generally positive numbers. Revenue remains relatively stable around $3 Billion.  The duplicated entry needs clarification.

**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2024-09-30 | $3.19B | 33.98% |
| 2024-06-30 | $2.99B | 32.82% |
| 2024-03-31 | $2.93B | 32.04% |
| 2023-12-31 | $3.00B | 31.03% |
| 2023-09-30 | $3.19B | 30.84% |


Revenue is relatively consistent, while profit margin shows a slight upward trend.


**Capital and Profitability:**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2024-09-30 | $17.04B | 11.45% |
| 2024-06-30 | $15.10B | 4.61% |
| 2024-03-31 | $14.91B | 3.84% |
| 2023-12-31 | $14.87B | 4.10% |
| 2023-09-30 | $14.31B | 4.84% |

Equity has increased significantly,  while ROE fluctuates; it was notably higher in Q3 2024.


**7. Overall Analysis:**

APD shows strong historical growth in certain periods, but recent performance has lagged the S&P 500.  Technical indicators (high RSI) suggest the stock is overbought. While recent earnings and financial data indicate generally positive results,  the projected long-term return relative to the S&P 500 is negative.  Further investigation into the reasons for recent underperformance and the duplicated earnings data entry is recommended before making any investment decisions.  The relatively low beta suggests less market volatility risk, but the low alpha and overbought conditions warrant caution.
